Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Change in Cash: 2019-2025

Historic Change in Cash for Benitec Biopharma (BNTC) over the last 7 years, with Jun 2025 value amounting to $46.9 million.

  • Benitec Biopharma's Change in Cash fell 115.74% to -$5.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was $46.9 million, marking a year-over-year decrease of 3.12%. This contributed to the annual value of $46.9 million for FY2025, which is 3.12% down from last year.
  • Benitec Biopharma's Change in Cash amounted to $46.9 million in FY2025, which was down 3.12% from $48.4 million recorded in FY2024.
  • In the past 5 years, Benitec Biopharma's Change in Cash ranged from a high of $48.4 million in FY2024 and a low of -$15.7 million during FY2022.
  • Over the past 3 years, Benitec Biopharma's median Change in Cash value was $46.9 million (recorded in 2025), while the average stood at $31.3 million.
  • As far as peak fluctuations go, Benitec Biopharma's Change in Cash tumbled by 257.58% in 2022, and later surged by 3,154.16% in 2024.
  • Yearly analysis of 5 years shows Benitec Biopharma's Change in Cash stood at $10.0 million in 2021, then plummeted by 257.58% to -$15.7 million in 2022, then spiked by 89.90% to -$1.6 million in 2023, then surged by 3,154.16% to $48.4 million in 2024, then fell by 3.12% to $46.9 million in 2025.